The Neuro-Immune Axis in Cardiomyopathy: Molecular Mechanisms, Clinical Phenotypes, and Therapeutic Frontiers
Open accessThe DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Abstract
Cardiomyopathies affect over 3 million individuals globally, with conventional treatments exhibiting up to 60% resistance and 25% 30-day readmission rates. This review synthesizes the current evidence on the role of neuro-immune interactions in the pathogenesis of cardiomyopathy and evaluates emerging therapies targeting this axis. We systematically examined clinical trials and mechanistic and multi-omics data across cardiomyopathy phenotypes, focusing on autonomic-immune dysregulation. Sympathetic overactivation, present in approximately 85% of patients, correlates with elevated pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) and contributes significantly to therapeutic non-response. Concurrent parasympathetic withdrawal impairs cholinergic anti-inflammatory pathways, as reflected by reduced heart rate variability and baroreflex sensitivity. At the molecular level, shared mechanisms include inflammasome activation, neuroimmune synaptic signaling, and neurogenic inflammation. Emerging therapies targeting this axis are promising. Vagus nerve stimulation, as demonstrated in the INOVATE-HF trial, improves functional outcomes, whereas IL-1β antagonists reduce cardiovascular events by 15–20% in the context of inflammatory diseases. Bioelectronic interventions, such as transcutaneous vagal nerve stimulation and baroreflex activation therapy, offer noninvasive dual-modulatory strategies that address both neural and immune pathways, positioning the neuroimmune axis as a central driver of cardiomyopathy, regardless of etiology. The integration of genetic and metabolomic profiling may enable precision therapies targeting neuroimmune circuits, thereby overcoming the limitations of hemodynamic-focused care. This mechanistic framework shifts the therapeutic paradigm from symptomatic relief to targeted modulation of pathogenic pathways, with implications for millions of patients with cardiomyopathy and broader inflammatory cardiovascular disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
Reactive Oxygen Species in Inflammation and Tissue Injury
Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P., & Malik, A. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5149 · Cited by 4,897
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481 · cited 1×
“Sympathetic nervous system overactivity elevates catecholamine levels, actively driving inflammation via oxidative stress and inflammatory mediator release [13,14], and chronic sympathetic activation further modulates immune cell phenotypes toward a pro-inflammatory state [15].”
Global burden of heart failure: a comprehensive and updated review of epidemiology
Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P., Rosano, G. M. C., & Coats, A. J. S. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac013 · Cited by 3,315
Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T.-B., Lee, S.-R., & Yang, S.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052719 · Cited by 1,694
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
Sternberg, E. M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1810 · Cited by 1,064
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Paik, S., Kim, J. K., Silwal, P., Sasakawa, C., & Jo, E.-K. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00670-3 · Cited by 892
Cardioimmunology: the immune system in cardiac homeostasis and disease
Swirski, F. K., & Nahrendorf, M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0065-8 · Cited by 849
Signaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831
The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation
Pavlov, V. A., Wang, H., Czura, C. J., Friedman, S. G., & Tracey, K. J. (2003) · Molecular Medicine · doi:10.1007/bf03402177 · Cited by 772 · cited 1×
“Parasympathetic withdrawal simultaneously compromises the anti-inflammatory mechanisms [16,17].”
Paur, H., Wright, P. T., Sikkel, M. B., Tranter, M. H., Mansfield, C., O'Gara, P., Stuckey, D. J., Nikolaev, V. O., Diakonov, I., Pannell, L., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.111591 · Cited by 767
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Mechanisms and Therapeutic Relevance of Neuro-immune Communication
Chavan, S. S., Pavlov, V. A., & Tracey, K. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.008 · Cited by 663
Velleca, A., Shullo, M. A., Dhital, K., Azeka, E., Colvin, M., DePasquale, E., Farrero, M., García-Guereta, L., Jamero, G., Khush, K., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.10.015 · Cited by 645
Sex Differences in Autoimmune Disease from a Pathological Perspective
Fairweather, D., Frisancho-Kiss, S., & Rose, N. R. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071008 · Cited by 629
Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy
Lymperopoulos, A., Rengo, G., & Koch, W. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300308 · Cited by 607
Richter, T., Nestler-Parr, S., Babela, R., Khan, Z. M., Tesoro, T., Molsen, E., & Hughes, D. A. (2015) · Value in Health · doi:10.1016/j.jval.2015.05.008 · Cited by 590
Sudden cardiac death: epidemiology and risk factors
Adabag, A. S., Luepker, R. V., Roger, V. L., & Gersh, B. J. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.3 · Cited by 430
The sympathetic nervous response in inflammation
Pongratz, G., & Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0504-2 · Cited by 427
Insulin Signaling and Heart Failure
Riehle, C., & Abel, E. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.306206 · Cited by 418
Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications
Singh, T., Khan, H., Gamble, D. T., Scally, C., Newby, D. E., & Dawson, D. (2022) · Circulation · doi:10.1161/circulationaha.121.055854 · Cited by 396
Paulus, W. J., & Zile, M. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318159 · Cited by 393
Vagus Nerve Stimulation for the Treatment of Heart Failure
Gold, M. R., Van Veldhuisen, D. J., Hauptman, P. J., Borggrefe, M., Kubo, S. H., Lieberman, R. A., Milasinovic, G., Berman, B. J., Djordjevic, S., Neelagaru, S., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.525 · Cited by 391
Zeng, C., Duan, F., Hu, J., Luo, B., Huang, B., Lou, X., Sun, X., Li, H., Zhang, X., Yin, S., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101523 · Cited by 384
Oduro, P. K., Zheng, X., Wei, J., Yang, Y., Wang, Y., Zhang, H., Liu, E., Gao, X., Du, M., & Wang, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.011 · Cited by 339
Huston, J. M., & Tracey, K. J. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02321.x · Cited by 339
Boehmer, T. K., Kompaniyets, L., Lavery, A. M., Hsu, J., Ko, J. Y., Yusuf, H., Romano, S. D., Gundlapalli, A. V., Oster, M. E., & Harris, A. M. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7035e5 · Cited by 310
Ridker, P. M., MacFadyen, J. G., Glynn, R. J., Koenig, W., Libby, P., Everett, B. M., Lefkowitz, M., Thuren, T., & Cornel, J. H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.490 · Cited by 297
Takotsubo cardiomyopathy: Pathophysiology, diagnosis and treatment
Komamura, K. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i7.602 · Cited by 270
Pathophysiology of arrhythmogenic cardiomyopathy
Basso, C., Bauce, B., Corrado, D., & Thiene, G. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.173 · Cited by 253
Exercise based rehabilitation for heart failure
Rees, K., Taylor, R. R., Singh, S., Coats, A. J., & Ebrahim, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003331.pub2 · Cited by 253
Kolman, B. S., Verrier, R. L., & Lown, B. (1975) · Circulation · doi:10.1161/01.cir.52.4.578 · Cited by 240
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230 · cited 1×
“Targeting tumor necrosis factor alpha (TNF-α ) has yielded mixed results; early nonspecific blockade was largely ineffective [118], but emerging evidence suggests that subtype-specific or temporally precise TNF-α inhibition may benefit selected patients [119].”
Women with hypertrophic cardiomyopathy have worse survival
Geske, J. B., Ong, K. C., Siontis, K. C., Hebl, V. B., Ackerman, M. J., Hodge, D. O., Miller, V. M., Nishimura, R. A., Oh, J. K., Schaff, H. V., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx527 · Cited by 225
Daniela, M., Catalina, L., Ilie, O., Paula, M., Daniel-Andrei, I., & Ioana, B. (2022) · Antioxidants · doi:10.3390/antiox11020350 · Cited by 224
Higashikuni, Y., Liu, W., Numata, G., Tanaka, K., Fukuda, D., Tanaka, Y., Hirata, Y., Imamura, T., Takimoto, E., Komuro, I., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.060860 · Cited by 219
COVID-19 and myocarditis: a systematic review and overview of current challenges
Castiello, T., Georgiopoulos, G., Finocchiaro, G., Claudia, M., Gianatti, A., Delialis, D., Aimo, A., & Prasad, S. (2022) · Heart Failure Reviews · doi:10.1007/s10741-021-10087-9 · Cited by 199
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Gatewood, S. J. L., Njoku, D. B., & Rose, N. R. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63241-5 · Cited by 198
The Sympathetic Nervous System and Heart Failure
Zhang, D. Y., & Anderson, A. S. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2013.09.010 · Cited by 194
Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation
Nishimura, R. A., Seggewiss, H., & Schaff, H. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.309348 · Cited by 178
Role of titin in cardiomyopathy: from DNA variants to patient stratification
Ware, J. S., & Cook, S. A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.190 · Cited by 174
The Interplay between Autonomic Nervous System and Inflammation across Systemic Autoimmune Diseases
Bellocchi, C., Carandina, A., Montinaro, B., Targetti, E., Furlan, L., Rodrigues, G. D., Tobaldini, E., & Montano, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052449 · Cited by 161
Olivieri, F., Biscetti, L., Pimpini, L., Pelliccioni, G., Sabbatinelli, J., & Giunta, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102521 · Cited by 148
Komegae, E. N., Farmer, D. G. S., Brooks, V. L., McKinley, M. J., McAllen, R. M., & Martelli, D. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.005 · Cited by 144
Lipshultz, S. E., Cochran, T. R., Briston, D. A., Brown, S. R., Sambatakos, P., Miller, T. L., Carrillo, A. A., Corcia, L., Sanchez, J. E., Diamond, M. B., et al. (2013) · Future Cardiology · doi:10.2217/fca.13.66 · Cited by 129
Bogle, C., Colan, S. D., Miyamoto, S. D., Choudhry, S., Hernandez, N. B., Brickler, M. M., Feingold, B., Lal, A. K., Lee, T. M., Canter, C. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001151 · Cited by 125
Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review
Asatryan, B., Asimaki, A., Landstrom, A. P., Khanji, M. Y., Odening, K. E., Cooper, L. T., Marchlinski, F. E., Gelzer, A. R., Semsarian, C., Reichlin, T., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.055890 · Cited by 120
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine
Gigli, M., Stolfo, D., Merlo, M., Sinagra, G., Taylor, M. R. G., & Mestroni, L. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01074-2 · Cited by 109
Double‐negative T cells: Setting the stage for disease control or progression
Velikkakam, T., Gollob, K. J., & Dutra, W. O. (2022) · Immunology · doi:10.1111/imm.13441 · Cited by 106
Takotsubo Syndrome and COVID-19: Associations and Implications
Shah, R. M., Shah, M., Shah, S., Li, A., & Jauhar, S. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100763 · Cited by 103
Adrenergic signaling and oxidative stress: a role for sirtuins?
Corbi, G., Conti, V., Russomanno, G., Longobardi, G., Furgi, G., Filippelli, A., & Ferrara, N. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00324 · Cited by 100
Neural Mechanisms in Cardiovascular Health and Disease
Ziegler, K. A., Engelhardt, S. H., Carnevale, D., McAlpine, C. S., Guzik, T. J., Dimmeler, S., & Świrski, F. K. (2025) · Circulation Research · doi:10.1161/circresaha.125.325580 · Cited by 100
Reduced estrogen in menopause may predispose women to takotsubo cardiomyopathy
Kuo, B. T., Choubey, R., & Novaro, G. M. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.01.006 · Cited by 91
Reactive oxygen species: players in the cardiovascular effects of testosterone
Tostes, R. C., Carneiro, F. S., Carvalho, M. H. C., & Reckelhoff, J. F. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00392.2014 · Cited by 90
Vagus Nerve Stimulation and Inflammation in Cardiovascular Disease: A State‐of‐the‐Art Review
Bazoukis, G., Stavrakis, S., & Armoundas, A. A. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030539 · Cited by 90
Mohanta, S. K., Yin, C., Weber, C., Godinho-Silva, C., Veiga-Fernandes, H., Xu, Q. J., Chang, R. B., & Habenicht, A. J. R. (2023) · Circulation Research · doi:10.1161/circresaha.123.322791 · Cited by 89
Papaioannou, V., Pneumatikos, I., & Maglaveras, N. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00174 · Cited by 85
Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications
Carnevale, D. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00678-w · Cited by 81
Antunes, M. D. O., & Scudeler, T. L. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100503 · Cited by 79
Siepmann, M., Weidner, K., Petrowski, K., & Siepmann, T. (2022) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-022-09572-0 · Cited by 77
Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy
Kyriakopoulou, E., Versteeg, D., de Ruiter, H., Perini, I., Seibertz, F., Döring, Y., Zentilin, L., Tsui, H., van Kampen, S. J., Tiburcy, M., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00378-9 · Cited by 71
Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy
Gerull, B., & Brodehl, A. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00532-z · Cited by 71
The Role of Oxidative Stress and Inflammatory Parameters in Heart Failure
Wróbel-Nowicka, K., Wojciechowska, C., Jacheć, W., Zalewska−Ziob, M., & Romuk, E. B. (2024) · Medicina · doi:10.3390/medicina60050760 · Cited by 70
Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: A biopsy study
Kawai, C., Yui, Y., Hoshino, T., Sasayama, S., & Matsumori, A. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80229-0 · Cited by 70
HIV-1 gp120 Activates the STAT3/Interleukin-6 Axis in Primary Human Monocyte-Derived Dendritic Cells
Cornò, M. D., Donninelli, G., Varano, B., Sacco, L. D., Masotti, A., & Gessani, S. (2014) · Journal of Virology · doi:10.1128/jvi.00307-14 · Cited by 67
Complement and Dilated Cardiomyopathy
Zwaka, T. P., Manolov, D., Özdemir, C., Marx, N., Kaya, Z., Kochs, M., Höher, M., Hombach, V., & Torzewski, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64201-0 · Cited by 66
Inflammation across the spectrum of hypertrophic cardiac phenotypes
Lillo, R., Graziani, F., Franceschi, F., Iannaccone, G., Massetti, M., Olivotto, I., Crea, F., & Liuzzo, G. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10307-4 · Cited by 62
Mindfulness-Based Interventions and the Hypothalamic–Pituitary–Adrenal Axis: A Systematic Review
Vargas‐Uricoechea, H., Castellanos-Pinedo, A., Urrego-Noguera, K., Vargas-Sierra, H. D., Fernández, M. V. P., Barceló, E., & Giraldo, A. F. R. (2024) · Neurology International · doi:10.3390/neurolint16060115 · Cited by 62
Panagiotou, A., Trendelenburg, M., & Osthoff, M. F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01151 · Cited by 58
Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
Wołowiec, Ł., Grześk, G., Osiak, J., Wijata, A., Mędlewska, M., Gaborek, P., Banach, J., Wołowiec, A., & Głowacka, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043714 · Cited by 58
Innate immune memory in cardiometabolic disease
Bahrar, H., Bekkering, S., Stienstra, R., Netea, M. G., & Riksen, N. P. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad030 · Cited by 58
Gronda, E., Seravalle, G., Trevano, F. Q., Costantino, G., Casini, A., Alsheraei, A., Lovett, E. G., Vanoli, E., Mancia, G., & Grassi, G. M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000603 · Cited by 51
Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy
Mavroidis, M., Davos, C. H., Psarras, S., Varela, A., Athanasiadis, N. C., Katsimpoulas, M., Kostavasili, I., Maasch, C., Vater, A., van Tintelen, J. P., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0485-6 · Cited by 49
Estrogen receptor β suppresses inflammation and the progression of prostate cancer
Xiao, L., Luo, Y., Tai, R., & Zhang, N. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10014 · Cited by 45
Merino del Portillo, M., Clemente-Suárez, V. J., Ruisoto, P., Jimenez, M., Ramos-Campo, D. J., Beltran-Velasco, A. I., Martínez-Guardado, I., Rubio-Zarapuz, A., Navarro-Jiménez, E., & Tornero-Aguilera, J. F. (2024) · Metabolites · doi:10.3390/metabo14100549 · Cited by 44
Inflammation in the Pathogenesis of Arrhythmogenic Cardiomyopathy: Secondary Event or Active Driver?
Meraviglia, V., Alcalde, M., Campuzano, Ó., & Bellin, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.784715 · Cited by 44
MicroRNAs in Macrophages: Regulators of Activation and Function
Sprenkle, N. T., Serezani, C. H., & Pua, H. H. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200467 · Cited by 41
Gargus, M., Ben‐Azu, B., Landwehr, A., Dunn, J., Errico, J. P., & Tremblay, M. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1527842 · Cited by 39
Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
Bollen, I. A. E., van Deel, E. D., Kuster, D. W. D., & van der Velden, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2014.00531 · Cited by 39
Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management
Yang, J., Chen, S., Duan, F., Wang, X., Zhang, X., Lian, B. X., Kou, M., Chiang, Z., Li, Z., & Lian, Q. (2022) · Cells · doi:10.3390/cells11213511 · Cited by 37
Bakalakos, A., Ritsatos, K., & Anastasakis, A. (2018) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2018.05.008 · Cited by 37
Buchmann, S. J., Lehmann, D., & Stevens, C. E. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00917 · Cited by 37
Pediatric dilated cardiomyopathy: a review of current clinical approaches and pathogenesis
Malinow, I., Fong, D. C., Miyamoto, M., Badran, S., & Hong, C. C. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1404942 · Cited by 37
Wu, S., Li, Y., Shi, Z., Lin, Z., Rao, Z., Tai, S., Chu, M., Li, L., & Lin, J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006510 · Cited by 36
Liao, S.-Y., Liu, Y., Zuo, M., Zhang, Y., Yue, W., Au, K., Lai, W., Wu, Y., Shuto, C., Chen, P., et al. (2015) · EP Europace · doi:10.1093/europace/euu409 · Cited by 35
Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers
Glavaški, M., Velicki, L., & Vučinić, N. (2023) · Medicina · doi:10.3390/medicina59081424 · Cited by 35
Gitler, A., Yosef, Y. B., Kotzer, U., & Levine, A. (2025) · Medicine International · doi:10.3892/mi.2025.236 · Cited by 34
Mukkawar, R. V., Reddy, H., Rathod, N., Kumar, S., & Acharya, S. (2024) · Cureus · doi:10.7759/cureus.66554 · Cited by 33
The Role of Neuroinflammation in the Comorbidity of Psychiatric Disorders and Internal Diseases
Cătălina, G. R., Gheorman, V., Gheorman, V., & Forțofoiu, M.-C. (2025) · Healthcare · doi:10.3390/healthcare13070837 · Cited by 32
Pro‐inflammatory cytokines as emerging molecular determinants in cardiolaminopathies
Gerbino, A., Forleo, C., Milano, S., Piccapane, F., Procino, G., Pepe, M., Piccolo, M., Guida, P., Resta, N., Favale, S., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16975 · Cited by 31
Lu, L., Ahmed, F. S., Akin, O., Luk, L., Guo, X., Yang, H., Yoon, J., Hakimi, A. A., Schwartz, L. H., & Zhao, B. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638185 · Cited by 31
Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue
Maione, A. S., Pilato, C. A., Casella, M., Gasperetti, A., Stadiotti, I., Pompilio, G., & Sommariva, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00279 · Cited by 31
Myocardial Immune Cells: The Basis of Cardiac Immunology
Cohen, C. D., Rousseau, S. T., Bermea, K. C., Bhalodia, A., Lovell, J. P., Zita, M. D., Čiháková, D., & Adamo, L. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200924 · Cited by 30
Sachdev, E., Merz, C. N. B., & Mehta, P. K. (2015) · European Cardiology Review · doi:10.15420/ecr.2015.10.01.25 · Cited by 29
Arrhythmogenic Cardiomyopathy—Current Treatment and Future Options
Migliore, F., Mattesi, G., Zorzi, A., Bauce, B., Rigato, I., Corrado, D., & Cipriani, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132750 · Cited by 29
Cardiac Sarcoidosis: A Comprehensive Clinical Review
Vereckei, A., Besenyi, Z., Nagy, V., Radics, B., Vágó, H., Jenei, Z. M., Katona, G., & Sepp, R. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2502037 · Cited by 29
The Molecular Role of Immune Cells in Dilated Cardiomyopathy
Wang, E., Zhou, R., Li, T., Hua, Y., Zhou, K., Li, Y., Luo, S., & An, Q. (2023) · Medicina · doi:10.3390/medicina59071246 · Cited by 28
Chronic vagus nerve stimulation in patients with heart failure: challenge or failed translation?
Wu, Z., Liao, J., Liu, Q., Zhou, S., & Chen, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1052471 · Cited by 27
Cardiomyopathies in Children and Systemic Disorders When Is It Useful to Look beyond the Heart?
Lodato, V., Parlapiano, G., Calì, F., Silvetti, M. S., Adorisio, R., Armando, M., Hachem, M. E., Romanzo, A., Dionisi‐Vici, C., Digilio, M. C., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9020047 · Cited by 26
Mo, X., Lü, P., & Yang, X. (2023) · Clinical Cardiology · doi:10.1002/clc.24085 · Cited by 25
(2021) · doi:10.22037/aaem.v9i1.1153 · Cited by 25
Takotsubo cardiomyopathy: A comprehensive review
Barmore, W., Patel, H., Harrell, S., Garcia, D., & Calkins, J. B. (2022) · World Journal of Cardiology · doi:10.4330/wjc.v14.i6.355 · Cited by 25
Lee, S.-C., Tsai, P.-H., Yu, K.-H., & Chan, T.-M. (2025) · Healthcare · doi:10.3390/healthcare13080952 · Cited by 25
Fibro-fatty remodelling in arrhythmogenic cardiomyopathy
Kohela, A., & van Rooij, E. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00929-4 · Cited by 25
COVID-19-Induced Myocarditis: Pathophysiological Roles of ACE2 and Toll-like Receptors
Pannucci, P., Jefferson, S. R., Hampshire, J., Cooper, S. L., Hill, S. J., & Woolard, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065374 · Cited by 24
Broken Heart Syndrome: Evolving Molecular Mechanisms and Principles of Management
Sethi, Y., Murli, H., Kaiwan, O., Vora, V., Agarwal, P., Chopra, H., Padda, I., Kanithi, M., Popoviciu, M. S., & Cavalu, S. D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010125 · Cited by 23
Cheng, X., He, S., Zhong, G., Meng, J., Wang, M., Bi, Q., & Tu, R. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03043-y · Cited by 23
Kurir, T. T. (2020) · Acta Clinica Croatica · doi:10.20471/acc.2020.59.02.19 · Cited by 21
Yoshikawa, T. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0373 · Cited by 21
Cardiac Immunology: A New Era for Immune Cells in the Heart
Koc, A., & Çağavi, E. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_576 · Cited by 21
Baris, R. O., & Tabit, C. E. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165894 · Cited by 20
Krych, S., Jęczmyk, A., Jurkiewicz, M., Żurek, M., Jekiełek, M., Kowalczyk, P., Kramkowski, K., & Hrapkowicz, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158127 · Cited by 20
Torp, M. K., Ranheim, T., Schjalm, C., Hjorth, M., Heiestad, C. M., Dalen, K. T., Nilsson, P. H., Mollnes, T. E., Pischke, S. E., Lien, E., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.870811 · Cited by 19
Comprehensive Review: Mavacamten and Aficamten in Hypertrophic Cardiomyopathy
Savsin, H., & Tokarek, T. (2025) · Biomedicines · doi:10.3390/biomedicines13071619 · Cited by 18
Akansel, S., Kofler, M., Praet, K. M. V., Unbehaun, A., Sündermann, S., Jacobs, S., Falk, V., & Kempfert, J. (2022) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivac163 · Cited by 18
Kusumawardhani, N. Y., Putra, I. C. S., Kamarullah, W., Afrianti, R., Pramudyo, M., Iqbal, M., Prameswari, H. S., Achmad, C., Tiksnadi, B. B., & Akbar, M. R. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2401028 · Cited by 18
Coscarella, I. L., Landim-Vieira, M., Pinto, J. R., & Chelko, S. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158753 · Cited by 17
Fan, X., Yang, G., Duru, F., Grilli, M., Akın, İ., Zhou, X., Saguner, A. M., & El‐Battrawy, I. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10615-0 · Cited by 17
Maron, B. J., Maron, M. S., Sherrid, M. V., & Rowin, E. J. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024566 · Cited by 16
Neuroimmunology of Cardiovascular Disease
Zarate, S. M., Kirabo, A., Hinton, A. O., Jr., & Santisteban, M. M. (2024) · Current Hypertension Reports · doi:10.1007/s11906-024-01301-8 · Cited by 16
Fatal SARS-CoV-2 Inflammatory Syndrome and Myocarditis in an Adolescent: A Case Report
Beaudry, J., Dietrick, B., Lammert, D. B., Constas, A., McCaw, J. M., Hammond, J., Buendia, M. A., Stein, J. E., Pekosz, A. S., Schuette, J. J., et al. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002978 · Cited by 16
Microneurography as a minimally invasive method to assess target engagement during neuromodulation
Verma, N., Knudsen, B. E., Gholston, A. K., Skubal, A. C., Blanz, S. L., Settell, M. L., Frank, J., Trevathan, J. K., & Ludwig, K. A. (2023) · Journal of Neural Engineering · doi:10.1088/1741-2552/acc35c · Cited by 14
Dicorato, M. M., Citarelli, G., Mangini, F., Alemanni, R., Albanese, M., Cicco, S., Greco, C. A., Forleo, C., Basile, P., Carella, M. C., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13051256 · Cited by 13
Efficacy of beta-blocker therapy in Takotsubo cardiomyopathy: A systematic review and meta-analysis
Mejia, R. A. R., Singh, A., Bahekar, A., & Gupta, A. K. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133483 · Cited by 13
Unveiling HPV's hidden link: Cardiovascular diseases and the viral intrigue
Dutta, P., Saha, D., Earle, M., Prasad, C. P., Singh, M. K., Darswal, M., Aggarwal, V., Naik, N., Yadav, R., Shankar, A., et al. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.02.001 · Cited by 12
Self-citationMatuskova, L., Czippelová, B., Turianiková, Z., Švec, D., Kolková, Z., Lasabová, Z., & Javorka, M. (2021) · Physiological Research · doi:10.33549/physiolres.934837 · Cited by 12
Enzan, N., Matsushima, S., Ide, T., Tohyama, T., Funakoshi, K., Higo, T., & Tsutsui, H. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13790 · Cited by 11
A rat model of orthopedic injury-induced hypercoagulability and fibrinolytic shutdown
Carter, K. T., Palei, A. C., Spradley, F. T., Witcher, B. M., Martin, L., Hester, R. L., & Kutcher, M. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002924 · Cited by 11
Zhong, G., Chen, C., Wu, S., Chen, J., Han, Y., Zhu, Q., Xu, M., Nie, Q., & Wang, L. (2023) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-23-112 · Cited by 10
Arrhythmias and Sudden Death: What is New in Hypertrophic Cardiomyopathy?
Rajan, D., Zörner, C. R., Hansen, M. L., & Tfelt‐Hansen, J. (2025) · Cardiac failure review · doi:10.15420/cfr.2024.38 · Cited by 10
Device Therapies: New Indications and Future Directions
Kumar, P., & Schwartz, J. (2014) · Current Cardiology Reviews · doi:10.2174/1573403x1101141106121553 · Cited by 10
Ivanova, M. M., Dao, J., Friedman, A., Kasaci, N., & Göker-Alpan, Ö. (2025) · Cells · doi:10.3390/cells14050322 · Cited by 10
Sattar, Y., Sandhyavenu, H., Patel, N. N., Victor, V., Patel, D., Hussain, B., Titus, A., Thyagaturu, H. S., Alraiyes, M., Atti, L., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.01.004 · Cited by 9
Baroreflex activation therapy through electrical carotid sinus stimulation
Jordan, J., Tank, J., Heusser, K., & Reuter, H. (2024) · Autonomic Neuroscience · doi:10.1016/j.autneu.2024.103219 · Cited by 9
Iezzi, L., Sorella, A., Galanti, K., Gallina, S., Chahal, C. A. A., Bauce, B., Cipriani, A., Providencia, R. A., Lopes, L. R., Ricci, F., et al. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf029 · Cited by 9
10.1016/b978-0-7020-7455-4.00040-6
(2000) · doi:10.1016/b978-0-7020-7455-4.00040-6 · Cited by 8
Ghorbanzadeh, M., Khosravirad, Z., Rostamzadeh, M., Azizi, S., Khodashenas, M., Shahraki, B. K., & Ghasemi, F. (2023) · Galen Medical Journal · doi:10.31661/gmj.v12i.3116 · Cited by 8
Thom, K., Kahl, B. S., Wagner, T., van Egmond-Fröhlich, A., Krainz, M., Frischer, T., Leeb, I., Schuster, C., Ehringer-Schetitska, D., Minkov, M., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.896252 · Cited by 7
Saha, D., Dutta, P., Rebello, K. R., Shankar, A., & Chakraborty, A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05236-9 · Cited by 7
Self-citationNew insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure
Li, J., Zhou, L., & Gong, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.903902 · Cited by 6
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury
Li, Z., Qin, L., Xu, X., Chen, R., Zhang, G., Wang, B., Li, B., & Chu, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1561946 · Cited by 6
Tao, J., Dou, X., Chen, L., Hu, F., Li, Z., Gao, H., Li, X., Zhang, M., & Hu, Z. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2508277 · Cited by 6
Chimeric Antigen Receptor CAR-T Therapy on the Move: Current Applications and Future Possibilities
Chakraborty, A., Dutta, P., Saha, D., Singh, M. K., Prasad, C. P., Pushpam, D., Shankar, A., & Saini, D. (2023) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-023-00046-x · Cited by 6
Self-citationCase report: Changes in the levels of stress hormones during Takotsubo syndrome
Ruiz, P. R., Gabarre, P., Chenevier‐Gobeaux, C., François, H., Kernéis, M., Cidlowski, J. A., Oakley, R. H., Lefèvre, G., & Boissan, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.931054 · Cited by 5
Novel Strategies for the Treatment of Heart Failure
Kehat, I. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10078 · Cited by 5
Precision medicine applications in dilated cardiomyopathy: Advancing personalized care
Khattab, E., Myrianthefs, M. M., Sakellaropoulos, S., Alexandrou, K., & Mitsis, A. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103076 · Cited by 4
Supervised exercise improves autonomic modulation in participants in cardiac rehabilitation programs
Nascimento, P. M. C., Vieira, M. C., Sperandei, S., & Serra, S. M. (2016) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2015.12.001 · Cited by 3
Clinical reasoning: Sherlock Holmes or Dr. Joseph Bell
(2022) · doi:10.1080/0142159x.2022.2044460 · Cited by 2
Research works printed but not linked: 1
- Mahmaljy, H., Yelamanchili, V.S., and Singhal, M. (2025, July 18). Dilated Cardiomyopathy, Available online: https://www.ncbi.nlm.nih.gov/books/NBK441911/.
Cited by
Aziz, F., Chakraborty, A., Saha, D., & Dutta, P. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1739021 · Cited by 9
Self-citationNeuro‐Immune Interaction: A New Therapeutic Target for Cardiovascular Diseases
Ma, X., Yang, K., Fan, A., Wang, B., Zhu, X., Hu, W., Fan, G., & Li, L. (2026) · Comprehensive physiology · doi:10.1002/cph4.70256
Chemical Epigenetics: Small Molecules Targeting Chromatin Modifiers in Disease Modulation
Alum, B. N., Echegu, D. A., & Alum, E. U. (2026) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-026-02049-5
Metadata
- Authors
- Saha, D., Dutta, P., & Chakraborty, A.
- Affiliations
- The University of Texas at El Paso (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Chakraborty, Abhijit
- Venue
- Immuno
- Publisher
- MDPI AG
- Published
- 2025-10-03
- Volume
- 5
- Issue
- 4
- Pages
- 45
- ISSN
- 2673-5601 (ISSN-L)
- OpenAlex
- W4414785507
- Cited by
- 3
- References
- 157
- Citations by year
- 2026: 3
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Immuno (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- cardiomyopathy, neuroimmune axis, sympathetic hyperactivity, parasympathetic withdrawal, inflammatory cytokines, cholinergic anti-inflammatory pathway, heart rate variability, baroreflex sensitivity, inflammasome activation, neurogenic inflammation, vagus nerve stimulation, baroreflex activation therapy, bioelectronic medicine, precision medicine, metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.